How I Treat ALL in First Complete Remission: Role of MRD and Molecular Genetics in Treatment Decisions
Upon viewing this session, you will be able to review the historical outcomes for adults with precursor B and T ALL, discuss the progress in therapeutic approach and treatment outcomes in adult ALL, discuss the prognostic impact of recently defined biological subsets in ALL, evaluate the impact of minimal residual disease detection on prognosis and treatment stratification, and discuss new targeted therapeutic strategies to eradicate MRD.
Wendy Stock, MD, University of Chicago
Active, International, Emeritus, and Honorary Members
Associate, International Associate, Student, and Resident Members